LuxExperience BV
F:0FV
LuxExperience BV
F:0FV
Price:
6.65
EUR
8.13%
Market Cap:
€912.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
LuxExperience BV
F:0FV
|
DE |
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
US |
|
Adex Mining Inc
XTSX:ADE
|
CA |
Balance Sheet
Balance Sheet Decomposition
LuxExperience BV
LuxExperience BV
Balance Sheet Decomposition is not available for
LuxExperience BV
LuxExperience BV
Balance Sheet
LuxExperience BV
LuxExperience BV
Currency: EUR
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
4
|
2
|
9
|
77
|
114
|
30
|
15
|
604
|
|
| Cash Equivalents |
4
|
2
|
9
|
77
|
114
|
30
|
15
|
604
|
|
| Total Receivables |
6
|
6
|
5
|
5
|
8
|
8
|
13
|
109
|
|
| Accounts Receivables |
6
|
6
|
5
|
5
|
8
|
8
|
12
|
97
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
12
|
|
| Inventory |
107
|
136
|
169
|
247
|
230
|
360
|
371
|
1 020
|
|
| Other Current Assets |
9
|
8
|
19
|
15
|
62
|
42
|
44
|
123
|
|
| Total Current Assets |
125
|
152
|
202
|
344
|
414
|
440
|
443
|
1 855
|
|
| PP&E Net |
33
|
28
|
29
|
23
|
39
|
92
|
89
|
257
|
|
| PP&E Gross |
33
|
28
|
29
|
23
|
39
|
92
|
89
|
257
|
|
| Accumulated Depreciation |
12
|
19
|
26
|
34
|
43
|
54
|
68
|
86
|
|
| Intangible Assets |
16
|
16
|
16
|
17
|
16
|
16
|
16
|
18
|
|
| Goodwill |
139
|
139
|
139
|
139
|
139
|
139
|
139
|
139
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
6
|
0
|
10
|
14
|
|
| Other Assets |
139
|
139
|
139
|
139
|
139
|
139
|
139
|
139
|
|
| Total Assets |
314
N/A
|
335
+7%
|
386
+15%
|
522
+35%
|
615
+18%
|
694
+13%
|
697
+0%
|
2 282
+228%
|
|
| Liabilities | |||||||||
| Accounts Payable |
31
|
29
|
36
|
44
|
45
|
71
|
85
|
286
|
|
| Accrued Liabilities |
7
|
16
|
27
|
10
|
7
|
6
|
9
|
34
|
|
| Short-Term Debt |
0
|
4
|
10
|
0
|
0
|
0
|
0
|
10
|
|
| Current Portion of Long-Term Debt |
5
|
5
|
6
|
5
|
5
|
8
|
9
|
32
|
|
| Other Current Liabilities |
17
|
20
|
26
|
65
|
105
|
109
|
114
|
373
|
|
| Total Current Liabilities |
61
|
74
|
105
|
124
|
162
|
194
|
218
|
736
|
|
| Long-Term Debt |
133
|
140
|
205
|
9
|
17
|
50
|
40
|
177
|
|
| Deferred Income Tax |
5
|
5
|
1
|
2
|
4
|
1
|
0
|
0
|
|
| Other Liabilities |
7
|
5
|
10
|
1
|
1
|
3
|
3
|
5
|
|
| Total Liabilities |
205
N/A
|
224
+9%
|
321
+44%
|
136
-58%
|
183
+34%
|
247
+35%
|
261
+6%
|
917
+252%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
113
|
114
|
63
|
384
|
430
|
446
|
434
|
1 369
|
|
| Other Equity |
5
|
3
|
2
|
2
|
2
|
2
|
1
|
4
|
|
| Total Equity |
108
N/A
|
111
+3%
|
64
-42%
|
386
+499%
|
432
+12%
|
447
+4%
|
436
-3%
|
1 365
+213%
|
|
| Total Liabilities & Equity |
314
N/A
|
335
+7%
|
386
+15%
|
522
+35%
|
615
+18%
|
694
+13%
|
697
+0%
|
2 282
+228%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
86
|
86
|
86
|
85
|
85
|
85
|
85
|
137
|
|
Switch to:
Switch to:
See Also
Discover More
